Profile data is unavailable for this security.
About the company
Vilin Bio Med Limited is an India-based company, which is engaged in the business of manufacturing and selling pharmaceutical products. The Company's primary products in manufacturing dosage forms include oral liquid (syrups/suspensions/dry powders) (beta & non-beta-lactam), tablets & capsules (beta & non-beta-lactam) and external preparations. Its products include cardiovascular drugs, musculoskeletal drugs, antibiotics drugs, central nervous system drugs, alimentary system drugs, genitourinary tract drugs, respiratory system & anti-allergic drugs, anti-diabetic drugs, multi-vitamins, minerals & amino acids supplements, miscellaneous drugs, liquid orals and external preparations. Its cardiovascular drugs include ATORVOSTATIN + Aspirin Capsules, Dapagliflozin 10 milligrams (mg) TAB, Fluvastatin Tablets 40 mg, PRASUGREL 10 mg tablets, and Cilnidipine five mg tablets. Its external preparations include calamine lotion, and ciprofloxacin, fluocinolone acetonide and clotrimazole ointment.
- Revenue in INR (TTM)--
- Net income in INR--
- Incorporated2005
- Employees--
- LocationVilin Bio Med LtdHYDERABAD 500009IndiaIND
- Phone+91 4 079618843
- Websitehttp://www.vilinbiomed.co.in/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ortin Global Ltd | 7.49m | -81.60m | 169.62m | -- | -- | -- | -- | 22.64 | -10.04 | -10.04 | 0.9277 | -- | -- | -- | -- | -- | -- | -3.46 | -- | -8.85 | -315.55 | 23.25 | -1,089.22 | -3.67 | -- | -19.02 | -- | -- | -64.93 | -58.32 | -8,490.81 | -- | -- | -- |
Saroja Pharma Industries India Ltd | -100.00bn | -100.00bn | 234.60m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -9.78 | -- | -6.97 | -- | -- | -- |
Vilin Bio Med Ltd | -100.00bn | -100.00bn | 251.80m | -- | -- | 2.90 | -- | -- | -- | -- | -- | 6.22 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.9741 | -- | 0.4159 | -- | -4.27 | -- | -72.38 | -- | -- | -- |